Afternoon update
Liquidia rallied on its litigation settlement while CoreWeave fell on financing concerns as hotter inflation pressured markets.


Liquidia surged as much as 43.90% in regular trading on its litigation settlement before easing to +25.51%. CoreWeave sank as much as 17.17% amid financing concerns and remains down 16.58% from yesterday's close. October 14 afternoon snapshot; trading is still underway.
- CoreWeave is down 16.58% to $64.91 from yesterday's close, near its session low. Chamath Palihapitiya's bond-yield post and Musk's "Yikes" response amplified borrowing concerns; CNBC reports yields near 15%. Financing plans add dilution concerns. Later reporting carried CEO Michael Intrator's defense that contracted backlog supports debt obligations, but shares show little recovery.
- Liquidia reached $38.58 before pulling back to $33.65, still up 25.51% from yesterday's close. Its settlement resolves pending litigation with United Therapeutics and preserves Yutrepia sales for pulmonary arterial hypertension, but ends PH-ILD promotion and requires about $380.7 million in net payments.
- Hotter-than-expected September CPI added pressure to the broader market. Headline inflation rose 0.6% month over month and 3.7% year over year; core rose 0.3% and 2.6%, respectively.
- Defensives lead the supplied sector snapshot: Healthcare is up 2.40% and Consumer Defensive gains 1.85%. Energy follows at +0.58%.
- Technology falls 3.21%, the weakest sector in the supplied snapshot. Communication Services declines 1.55% and Industrials slips 1.42%, while healthcare and consumer defensives hold gains.
Overall, hotter inflation and AI financing concerns weigh on risk appetite, while healthcare and consumer defensives lead. Liquidia's settlement rally remains substantial despite its pullback and the deal's costs; CoreWeave remains near its session low despite management's defense.
